Vybe Medical
About
Vybe Medical combines AI-assisted therapy tools with licensed human therapists for affordable mental healthcare. Their platform reduces therapist administrative burden by 60%, enabling lower session costs ($65 vs $150+ industry average). 25K active patients across 15 states.
AI Investment Summary
AI-assisted therapy platform with 25K patients at $65/session. $6M ARR with 60% lower admin costs than traditional practice.
Structure
Reg CF Equity
Stage
Series A
Accreditation
Open to All
Liquidity
Illiquid
Geography
New York, NY
Revenue
revenue generating
Funding Progress
58%Total Investors
1,800
Green Flags
- $200 minimum
- $6M ARR growing rapidly
- 25K active patients
- AI reduces costs — not replaces therapists
Risk Flags
- Mental health regulation varies by state
- AI in therapy faces ethical scrutiny
- Insurance reimbursement uncertainty
- Competitive telehealth market
Similar Deals in Healthcare
DNA Chat (Mendly Care)
Seed
AI telemedicine + genome sequencing platform — $400 per genome.
Min. Investment
$100
Funded
25%
Breath Diagnostics
Seed
Detecting diseases with a single breath — non-invasive diagnostics.
Min. Investment
$100
NeuralMed
Series A
FDA-cleared AI cancer detection — 97% accuracy, deployed at 45 hospitals.
Min. Investment
$250
Funded
64%
Minimum Investment
$200
Valuation
$35M
Lock-up Period
3+ years
Tags
LISTED
2026-02-08
ANNUAL REVENUE
$6M ARR